Little Green Pharma’s QUEST Study Shows Promising Results for Medicinal Cannabis

The latest update is out from Little Green Pharma Ltd. ( (AU:LGP) ).

Little Green Pharma Ltd. has announced the results of the QUEST Initiative, a significant longitudinal study on the effects of medicinal cannabis on chronic conditions. The study, which involved 2,353 patients, demonstrated clinically meaningful improvements in health-related quality of life, fatigue, sleep, anxiety, depression, and pain. The findings, now published in PLOS One, highlight the potential of medicinal cannabis as a treatment option, with a notable increase in patient claims for cannabis treatments. This positions LGP as a key player in the medicinal cannabis market, supported by endorsements from various national health bodies.

More about Little Green Pharma Ltd.

Little Green Pharma Ltd. operates in the medicinal cannabis industry, focusing on the production and supply of cannabis-based products. The company is an Australian producer known for providing medicinal cannabis oils, which are used to improve health-related quality of life for patients with chronic conditions.

Average Trading Volume: 159,440

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$37.92M

Find detailed analytics on LGP stock on TipRanks’ Stock Analysis page.